Article Versions Notes

Chen P-C, Su B-C, Ma T-L, Hong YC, Chen Y-W, Vo TTT, Wu L-Y, Peng T-Y, Wang C-S, Lee I-T. Enhancement of Anticancer Effects by Combining 5-Fluorouracil with Refametinib in Human Oral Squamous Cell Carcinoma Cell Line. Applied Sciences. 2023; 13(7):4340. https://doi.org/10.3390/app13074340

Chen, Po-Chun, Bor-Chyuan Su, Tien-Li Ma, Ying Chui Hong, Yu-Wen Chen, Thi Thuy Tien Vo, Luo-Yun Wu, Tzu-Yu Peng, Ching-Shuen Wang, and I-Ta Lee. 2023. "Enhancement of Anticancer Effects by Combining 5-Fluorouracil with Refametinib in Human Oral Squamous Cell Carcinoma Cell Line" Applied Sciences 13, no. 7: 4340. https://doi.org/10.3390/app13074340

Chen, P.-C., Su, B.-C., Ma, T.-L., Hong, Y. C., Chen, Y.-W., Vo, T. T. T., Wu, L.-Y., Peng, T.-Y., Wang, C.-S., & Lee, I.-T. (2023). Enhancement of Anticancer Effects by Combining 5-Fluorouracil with Refametinib in Human Oral Squamous Cell Carcinoma Cell Line. Applied Sciences, 13(7), 4340. https://doi.org/10.3390/app13074340